The physiologic role of CD19 cytoplasmic tyrosines

Immunity

Volumn 17, Issue 4, 2002, Pages 501-514

  Wang, Yue ^a   Brooks, Stephen R ^a   Li, Xiaoli ^b   Anzelon, Amy N ^d   Rickert, Robert C ^d   Carter, Robert H ^a,b,c  

^a Department of Microbiology ^*  (United States)

^b University of Alabama at Birmingham   (United States)

^c BIRMINGHAM VA MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; T LYMPHOCYTE ANTIBODY; TYROSINE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN FUNCTION; ARTICLE; B LYMPHOCYTE; CELL CYCLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; GERMINAL CENTER; MOUSE; MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE; TRANSGENICS;

EID: 0036797376     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(02)00426-0     Document Type: Article

References (44)

1. Brooks S.R., Li X., Volanakis E.J., Carter R.H. Systematic analysis of the role of CD19 cytoplasmic tyrosines in enhancement of activation in Daudi human B cells. clustering of Phospholipase C and Vav and of Grb2 and Sos with different CD19 tyrosines J. Immunol. 164:2000;3123-3131.
2. Buhl A.M., Cambier J.C. Phosphorylation of CD19 Y484 and Y515, and linked activation of Phosphatidylinositol 3-kinase, are required for B cell antigen receptor-mediated activation of Bruton's tyrosine kinase. J. Immunol. 162:1999;4438-4446.
3. 2+ mobilization J. Exp. Med. 186:1997;1897-1910.
4. Carter R.H., Fearon D.T. CD19. lowering the threshold for antigen receptor stimulation of b lymphocytes Science. 256:1992;105-107.
5. Chalupny N.J., Aruffo A., Esselstyn J.M., Chan P.Y., Bajorath J., Blake J., Gilliland L.K., Ledbetter J.A., Tepper M.A. Specific binding of Fyn and phosphatidylinositol 3-kinase to the B cell surface glycoprotein CD19 through their src homology 2 domains. Eur. J. Immunol. 25:1995;2978-2984.
6. Cherukuri A., Cheng P., Sohn H., Pierce S. The CD19/CD21 complex functions to prolong B cell antigen receptor signaling from lipid rafts. Immunity. 14:2001;168-179.
7. Driver D.J., McHeyzer-Williams L.J., Cool M., Stetson D.B., McHeyzer-Williams M.G. Development and maintenance of a B220- memory B cell compartment. J. Immunol. 167:2001;1393-1405.
8. Engel P., Zhou L.-J., Ord D.C., Sato S., Koller B., Tedder T.F. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity. 3:1995;39-50.
9. Fagarasan S., Honjo T. T-independent immune response. new aspects of B cell biology Science. 290:2000;89-92.
10. Fearon D.T., Carroll M.C. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18:2000;393-422.
11. Fruman D.A., Snapper S.B., Yballe C.M., Davidson L., Yu J.Y., Alt F.W., Cantley L.C. Impaired B cell development and proliferation in absence of Phosphoinositide 3-kinase p85α Science. 283:1999;393-397.
12. Fujimoto M., Poe J.C., Inaoki M., Tedder T.F. CD19 regulates B lymphocyte responses to transmembrane signals. Semin. Immunol. 10:1998;267-277.
13. Fujimoto M., Poe J.C., Jansen P.J., Sato S., Tedder T.F. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation. J. Immunol. 162:1999;7088-7094.
14. Fujimoto M., Fujimoto Y., Poe J., Jansen P., Lowell C., DeFranco A., Tedder T. CD19 regulates Src family protein tyrosine kinase activation in B lymphocytes through processive amplification. Immunity. 13:2000;46-57.
15. Fujimoto M., Poe J.C., Hasegawa M., Tedder T.F. CD19 amplification of B lymphocyte Ca2+ responses. a role for Lyn sequestration in extinguishing negative regulation J. Biol. Chem. 276:2001;44820-44827.
16. Guinamard R., Okigaki M., Schlessinger J., Ravetch J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1:2000;31-36.
17. Hodgkin P.D., Lee J.H., Lyons A.B. B cell differentiation and isotype switching is related to division cycle number. J. Exp. Med. 184:1996;277-281.
18. Jacob J., Przylepa J., Miller C., Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. III. The kinetics of V region mutation and selection in germinal center B cells. J. Exp. Med. 178:1993;1293-1307.
19. Kraus M., Pao L.I., Reichlin A., Hu Y., Canono B., Cambier J.C., Nussenzweig M.C., Rajewsky K. Interference with immunoglobulin (Ig)α immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igβ cytoplasmic tail. J. Exp. Med. 194:2001;455-469.
20. Li X., Carter R.H. Convergence of CD19 and B cell antigen receptor signals in the ERK2 activation cascade. J. Immunol. 161:1998;5901-5908.
21. Li X., Carter R. CD19 signal transduction in normal human B cells. linkage to downstream pathways requires Phosphatidylinositol 3-kinase, protein kinase C and Ca2+ Eur. J. Immunol. 30:2000;1576-1586.
22. Li X., Sandoval D., Freeberg L., Carter R.H. Role of CD19 tyrosine 391 in synergistic activation of B lymphocytes by coligation of CD19 and membrane Ig. J. Immunol. 158:1997;5649-5657.
23. Li X., Martin F., Oliver A., Kearney J., Carter R. Antigen receptor proximal signaling in splenic B-2 cell subsets. J. Immunol. 166:2001;3122-3199.
24. Martin F., Kearney J.F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity. 12:2000;39-49. a.
25. Martin F., Kearney J.F. B-cell subsets and the mature preimmune repertoire. Marginal zone and B. 1(B cells as part of a "natural immune memory". Immunol. Rev. 175):2000;70-79. b.
26. Martin F., Oliver A.M., Kearney J.F. Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity. 14:2001;617-629.
27. Matsumoto A.K., Martin D.R., Carter R.H., Klickstein L.B., Ahearn J., Fearon D.T. Functional dissection of the CD21/CD19/TAPA-1/Leu-13 complex of B lymphocytes. J. Exp. Med. 178:1993;1407-1417.
28. - memory B cell compartment J. Exp. Med. 191:2000;1149-1166.
29. O'Rourke L.M., Tooze R., Turner M., Sandoval D.M., Carter R.H., Tybulewicz V.L.J., Fearon D.T. CD19 as a membrane-anchored adaptor protein of B lymphocytes. costimulation of lipid and protein kinases by recruitment of Vav Immunity. 8:1998;635-645.
30. Okada T., Maeda A., Iwamatsu A., Gotoh K., Kurosaki T. Bcap. The tyrosine kinase substrate that connects b cell receptor to phosphoinositide 3-kinase activation Immunity. 13:2000;817-827.
31. Okkenhaug K., Wu L., Garza K.M., La Rose J., Khoo W., Odermatt B., Mak T.W., Ohashi P.S., Rottapel R. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2:2001;325-332.
32. Oliver A.M., Martin F., Kearney J.F. Mouse CD38 is down-regulated on germinal center B cells and mature plasma cells. J. Immunol. 158:1997;1108-1115.
33. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J. Immunol. 162:1999;7198-7207.
34. Otero D.C., Omori S.A., Rickert R.C. CD19-dependent activation of Akt kinase in B-lymphocytes. J. Biol. Chem. 276:2001;1474-1478.
35. Rickert R.C., Rajewsky K., Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature. 376:1995;352-355.
36. Sato S., Steeber D.A., Tedder T.F. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA. 92:1995;11558-11562.
37. Sato S., Hasegawa M., Fujimoto M., Tedder T.F., Takehara K. Quantitative genetic variation in CD19 expression correlates with autoimmunity. J. Immunol. 165:2000;6635-6643.
38. Shih T.A., Roederer M., Nussenzweig M.C. Role of antigen receptor affinity in T cell-independent antibody responses in vivo. Nat. Immunol. 3:2002;399-406.
39. Shinall S.M., Gonzalez-Fernandez M., Noelle R.J., Waldschmidt T.J. Identification of murine germinal center B cell subsets defined by the expression of surface isotypes and differentiation antigens. J. Immunol. 164:2000;5729-5738.
40. Suzuki H., Terauchi Y., Fujiwara M., Aizawa S., Yazaki Y., Kadowaki T. Xid-like immunodeficiency in mice with disruption of the p85α subunit of Phosphatidylinositol 3-kinase. Science. 283:1999;390-392.
41. Tanigaki K., Han H., Yamamoto N., Tashiro K., Ikegawa M., Kuroda K., Suzuki A., Nakano T., Honjo T. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3:2002;443-450.
42. Tedder T.F., Isaacs C.M. Isolation of cDNAs encoding the CD19 antigen of human and mouse B lymphocytes. a new member of the immunoglobulin superfamily J. Immunol. 143:1989;712-717.
43. Tedder T., Inaoki M., Sato S. The CD19-CD21 complex regulates signal transduction thresholds governing humoral immunity and autoimmunity. Immunity. 6:1997;107-118.
44. Tuveson D.A., Carter R.H., Soltoff S.P., Fearon D.T. CD19 of B cells as a surrogate kinase insert region to bind Phosphatidylinositol 3-kinase. Science. 260:1993;986-989.